UniProt ID | ADA1B_HUMAN | |
---|---|---|
UniProt AC | P35368 | |
Protein Name | Alpha-1B adrenergic receptor | |
Gene Name | ADRA1B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 520 | |
Subcellular Localization |
Nucleus membrane Multi-pass membrane protein. Cell membrane Multi-pass membrane protein . Cytoplasm . Membrane, caveola . Location at the nuclear membrane facilitates heterooligomerization and regulates ERK-mediated signaling in cardiac myocytes. |
|
Protein Description | This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes.. | |
Protein Sequence | MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQCRGRGRRRRRRRRRLGGCAYTYRPWTRGGSLERSQSRKDSLDDSGSCLSGSQRTLPSASPSPGYLGRGAPPPVELCAFPEWKAPGALLSLPAPEPPGRRGRHDSGPLFTFKLLTEPESPGTDGGASNGGCEAAADVANGQPGFKSNMPLAPGQF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | N-linked_Glycosylation | PDLDTGHNTSAPAHW CCCCCCCCCCCCCCH | 36.75 | UniProtKB CARBOHYD | |
24 | N-linked_Glycosylation | WGELKNANFTGPNQT HHCCCCCCCCCCCCC | 44.39 | UniProtKB CARBOHYD | |
29 | N-linked_Glycosylation | NANFTGPNQTSSNST CCCCCCCCCCCCCCC | 60.14 | UniProtKB CARBOHYD | |
34 | N-linked_Glycosylation | GPNQTSSNSTLPQLD CCCCCCCCCCCCHHH | 38.49 | UniProtKB CARBOHYD | |
144 | Phosphorylation | CAISIDRYIGVRYSL HHHHHHHCCCCHHCC | 9.77 | 11136215 | |
149 | Phosphorylation | DRYIGVRYSLQYPTL HHCCCCHHCCCCCCH | 16.01 | 9426637 | |
153 | Phosphorylation | GVRYSLQYPTLVTRR CCHHCCCCCCHHHHH | 11.95 | 9426651 | |
227 | Phosphorylation | LVMYCRVYIVAKRTT HHHHHHHHHHCCCCC | 3.13 | 28060719 | |
233 | Phosphorylation | VYIVAKRTTKNLEAG HHHHCCCCCCCCHHH | 41.22 | 23312004 | |
234 | Phosphorylation | YIVAKRTTKNLEAGV HHHCCCCCCCCHHHH | 23.20 | 23312004 | |
246 | Phosphorylation | AGVMKEMSNSKELTL HHHHHHHCCCCEEEE | 38.76 | 23312004 | |
248 | Phosphorylation | VMKEMSNSKELTLRI HHHHHCCCCEEEEEE | 21.87 | 23312004 | |
249 | Ubiquitination | MKEMSNSKELTLRIH HHHHCCCCEEEEEEE | 62.08 | 33845483 | |
264 | Phosphorylation | SKNFHEDTLSSTKAK CCCCCHHHHHCCCCC | 26.09 | - | |
266 | Phosphorylation | NFHEDTLSSTKAKGH CCCHHHHHCCCCCCC | 37.75 | 28348404 | |
267 | Phosphorylation | FHEDTLSSTKAKGHN CCHHHHHCCCCCCCC | 36.72 | 22777824 | |
269 | Ubiquitination | EDTLSSTKAKGHNPR HHHHHCCCCCCCCCC | 50.47 | 33845483 | |
365 | S-palmitoylation | AFVRILGCQCRGRGR HHHHHHCCCCCCCCH | 2.86 | - | |
389 | Methylation | GGCAYTYRPWTRGGS CCCCCCCCCCCCCCC | 16.69 | - | |
389 | Dimethylation | GGCAYTYRPWTRGGS CCCCCCCCCCCCCCC | 16.69 | - | |
393 | Methylation | YTYRPWTRGGSLERS CCCCCCCCCCCCCCC | 43.54 | - | |
393 | Dimethylation | YTYRPWTRGGSLERS CCCCCCCCCCCCCCC | 43.54 | - | |
396 | Phosphorylation | RPWTRGGSLERSQSR CCCCCCCCCCCCCCC | 29.85 | 9353340 | |
399 | Methylation | TRGGSLERSQSRKDS CCCCCCCCCCCCCCC | 45.34 | - | |
399 | Dimethylation | TRGGSLERSQSRKDS CCCCCCCCCCCCCCC | 45.34 | - | |
402 | Phosphorylation | GSLERSQSRKDSLDD CCCCCCCCCCCCCCC | 42.41 | 9353340 | |
403 | Methylation | SLERSQSRKDSLDDS CCCCCCCCCCCCCCC | 38.88 | - | |
403 | Dimethylation | SLERSQSRKDSLDDS CCCCCCCCCCCCCCC | 38.88 | - | |
406 | Phosphorylation | RSQSRKDSLDDSGSC CCCCCCCCCCCCCCC | 36.41 | 28857561 | |
410 | Phosphorylation | RKDSLDDSGSCLSGS CCCCCCCCCCCCCCC | 32.07 | 25985 | |
412 | Phosphorylation | DSLDDSGSCLSGSQR CCCCCCCCCCCCCCC | 18.81 | 9353340 | |
417 | Phosphorylation | SGSCLSGSQRTLPSA CCCCCCCCCCCCCCC | 17.08 | 144827 | |
470 | Phosphorylation | GRRGRHDSGPLFTFK CCCCCCCCCCCEEEE | 35.86 | 27422710 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ADA1B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ADA1B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ADA1B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AP2M1_HUMAN | AP2M1 | physical | 12644451 | |
ADA1B_HUMAN | ADRA1B | physical | 12888550 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
D00076 | Noradrenaline (JP16); Norepinephrine (INN); Nor adrenalin (TN) | |||||
D00095 | Adrenaline (JP16); Epinephrine (USP/INN); Adrenalin (TN); Auvi-q (TN); Epipen (TN) | |||||
D00124 | Ephedrine (USP); Ephedrine (TN) | |||||
D00255 | Carvedilol (JAN/USAN/INN); Artist (TN); Coreg (TN) | |||||
D00283 | Clozapine (JAN/USP/INN); Clozaril (TN) | |||||
D00403 | Levomepromazine (USAN/INN); Methotrimeprazine (USP); Levoprome (TN) | |||||
D00426 | Risperidone (JP16/USAN/INN); Risperdal (TN) | |||||
D00454 | Olanzapine (JAN/USAN/INN); Zyprexa (TN) | |||||
D00458 | Quetiapine fumarate (JP16/USAN); Seroquel (TN) | |||||
D00485 | Pseudoephedrine hydrochloride (USP); Sudafed (TN) | |||||
D00507 | Phenoxybenzamine hydrochloride (USP); Dibenzyline (TN) | |||||
D00509 | Phentolamine mesilate (JAN/INN); Phentolamine mesylate (USP); Regitine (TN) | |||||
D00511 | Phenylephrine hydrochloride (JP16/USP); Neo-synephrine (TN) | |||||
D00560 | Pimozide (JP16/USP/INN); Orap (TN) | |||||
D00561 | Sertindole (USAN/INN); SerLect (TN) | |||||
D00600 | Labetalol hydrochloride (JP16/USP); Normodyne (TN); Trandate (TN) | |||||
D00607 | Guanadrel sulfate (USP); Hylorel (TN) | |||||
D00608 | Doxazosin mesilate (JP16); Doxazosin mesylate (USAN); Cardura (TN) | |||||
D00609 | Prazosin hydrochloride (JP16/USP); Minipress (TN) | |||||
D00610 | Terazosin hydrochloride hydrate (JAN); Terazosin hydrochloride (USAN); Hytrin (TN) | |||||
D00636 | Amiodarone hydrochloride (JP16/USAN); Ancaron (TN); Cordarone (TN) | |||||
D00679 | Ergotamine tartrate (JP16/USP); Ergomar (TN) | |||||
D00680 | Methylergometrine maleate (JP16); Methylergonovine maleate (USP); Methergine (TN) | |||||
D00743 | Naphazoline hydrochloride (JP16/USP); Albalon (TN); Vasocon (TN) | |||||
D00756 | Tetrahydrozoline nitrate (JAN); Narbel (TN) | |||||
D00757 | Xylometazoline hydrochloride (USP); Neo-Synephrine II (TN) | |||||
D00996 | Epinephrine hydrochloride (JAN); Adrenalin chloride (TN) | |||||
D00997 | Tolazoline hydrochloride (JAN/USP); Priscoline (TN) | |||||
D01017 | Dipivefrin hydrochloride (JAN/USP); Propine (TN) | |||||
D01019 | Metaraminol bitartrate (JAN/USP); Aramine (TN) | |||||
D01020 | Methoxamine hydrochloride (JAN); Vasoxyl (TN) | |||||
D01021 | Naphazoline nitrate (JP16); Privine (TN) | |||||
D01022 | Oxymetazoline hydrochloride (JAN/USP); Ocuclear (TN) | |||||
D01023 | Tetrahydrozoline hydrochloride (JAN/USP); Tyzine (TN) | |||||
D01024 | Tamsulosin hydrochloride (JP16/USAN); Flomax (TN); Harnal (TN) | |||||
D01025 | Levobunolol hydrochloride (JAN/USP); Betagan (TN) | |||||
D01163 | Ergometrine maleate (JP16); Ergonovine maleate (USP); Ergometrine (TN) | |||||
D01290 | Nicergoline (JP16/USAN/INN); Sermion (TN) | |||||
D01307 | Midodrine hydrochloride (JAN/USAN); Pro-Amatine (TN) | |||||
D01333 | Urapidil (JP16/INN); Ebrantil (TN) | |||||
D01347 | Tramazoline hydrochloride (JAN/USAN); Towk (TN) | |||||
D01358 | Mianserin hydrochloride (JAN/USAN); Tetramide (TN) | |||||
D01386 | Ephedrine hydrochloride (JP16/USP); Ephedrine hydrochloride (TN) | |||||
D01405 | Norfenefrine hydrochloride (JAN); Zondel (TN) | |||||
D01444 | Bunitrolol hydrochloride (JAN); Betrilol (TN) | |||||
D01445 | Ifenprodil tartrate (JP16); Cerocral (TN) | |||||
D01469 | Amosulalol hydrochloride (JP16); Lowgan (TN) | |||||
D01520 | Levomepromazine hydrochloride (JAN/USAN); Nozinan (TN) | |||||
D01571 | Moxisylyte hydrochloride (JAN); Opilon (TN) | |||||
D01573 | Etilefrine hydrochloride (JP16); Etilefrine hydrochloride (TN) | |||||
D01674 | Naftopidil (JAN/INN); Flivas (TN) | |||||
D01691 | Nipradilol (JAN/INN); Hypadil (TN) | |||||
D01692 | Alfuzosin hydrochloride (JAN/USAN); Uroxatral (TN) | |||||
D01830 | Arotinolol hydrochloride (JP16); Almarl (TN) | |||||
D01887 | Bunazosin hydrochloride (JP16); Detantol (TN) | |||||
D01952 | L-Methylephedrine hydrochloride (JAN) | |||||
D01965 | Silodosin (JAN/INN); KMD 3213; Rapaflo (TN); Urief (TN) | |||||
D02034 | Setiptiline maleate (JAN); Tecipul (TN) | |||||
D02109 | dl-Methylephedrine hydrochloride (JP16); Methy-F (TN) | |||||
D02149 | Epinephrine bitartrate (JAN/USP); Asmatane mist (TN); Medihaler-epi (TN) | |||||
D02211 | Dihydroergotamine mesilate (JP16); Dihydroergotamine mesylate (USP); Migranal (TN) | |||||
D02248 | Levomepromazine maleate (JP16/USAN); Hirnamin (TN) | |||||
D02349 | Dipivefrin (USAN); Dipivefrine (INN) | |||||
D02363 | Ketanserin (USAN/INN) | |||||
D02537 | Dronedarone (INN) | |||||
D02901 | Amidephrine mesylate (USAN); Amidefrine mesilate (INN) | |||||
D02910 | Amiodarone (USAN/INN) | |||||
D02976 | Arbutamine hydrochloride (USAN); Genesa (TN) | |||||
D02995 | Asenapine maleate (USAN); Saphris (TN) | |||||
D03415 | Carvedilol phosphate hydrate (JAN); Carvedilol phosphate (USAN); Coreg CR (TN) | |||||
D03648 | Dapiprazole hydrochloride (USAN); Rev-Eyes (TN) | |||||
D03914 | Dronedarone hydrochloride (USAN); Multaq (TN) | |||||
D04018 | Ephedrine sulfate (USP); Isofedrol (TN) | |||||
D04531 | Indoramin (USAN/INN) | |||||
D04532 | Indoramin hydrochloride (USAN) | |||||
D04888 | Medroxalol (USAN/INN) | |||||
D04889 | Medroxalol hydrochloride (USAN) | |||||
D05206 | Norepinephrine bitartrate (USP); Levophed (TN) | |||||
D05395 | Pelanserin hydrochloride (USAN) | |||||
D05648 | Pseudoephedrine polistirex (USAN); Pseudo-12 (TN) | |||||
D05649 | Pseudoephedrine sulfate (USP); Afrinol (TN) | |||||
D06234 | Trimazosin hydrochloride (USAN); Trimazosin hydrochloride monohydrate | |||||
D06623 | Olanzapine pamoate (USAN); Olanzapine pamoate monohydrate | |||||
D07124 | Alfuzosin (INN); Xatral (TN) | |||||
D07148 | Oxedrine (BAN); (+/-)-Synephrine | |||||
D07451 | Amosulalol (INN) | |||||
D07465 | Arotinolol (INN) | |||||
D07550 | Bunazosin (INN) | |||||
D07837 | Dihydroergotamine (INN); Neomigran (TN) | |||||
D07838 | Dihydroergotamine tartrate; Divegal (TN) | |||||
D07874 | Doxazosin (INN); Cardura XL (TN) | |||||
D07905 | Ergometrine (INN) | |||||
D07906 | Ergotamine (INN) | |||||
D07931 | Etilefrine (INN); Corcanfol (TN) | |||||
D08064 | Ifenprodil (INN) | |||||
D08099 | Ketanserin tartrate; Sufrexal (TN) | |||||
D08106 | Labetalol (INN) | |||||
D08115 | Levobunolol (INN) | |||||
D08192 | Metaraminol (INN) | |||||
D08201 | Methoxamine (BAN) | |||||
D08206 | Methylephedrine (BAN) | |||||
D08207 | Methylergometrine (INN); Ergotyl (TN) | |||||
D08212 | Trimazosin (INN) | |||||
D08216 | Mianserin (INN); Tolvon (TN) | |||||
D08220 | Midodrine (INN) | |||||
D08239 | Moxisylyte (INN); Carlytene (TN) | |||||
D08253 | Naphazoline (INN); Nafazolin (TN) | |||||
D08271 | Nicergoline tartrate; Sermion (TN) | |||||
D08284 | Norepinephrine hydrochoride; (-)-Noradrenaline hydrochloride; Arterenol (TN) | |||||
D08286 | Norfenefrine (INN) | |||||
D08308 | Oxedrine tartrate; Dacryoboraline (TN) | |||||
D08309 | Oxedrine hydrochloride; Ocuton (TN) | |||||
D08322 | Oxymetazoline (INN); Operil (TN) | |||||
D08358 | Phenoxybenzamine (INN) | |||||
D08362 | Phentolamine (INN) | |||||
D08365 | Phenylephrine (INN); Phenylephrine Minims (TN) | |||||
D08366 | Phenylephrine tartrate; L-Phenylephrine tartrate; Boraline (TN) | |||||
D08411 | Prazosin (INN); Minipress (TN) | |||||
D08449 | Pseudoephedrine (INN); Neodurasina (TN); Acunaso (TN) | |||||
D08456 | Quetiapine (INN); Norsic (TN) | |||||
D08511 | Setiptiline (INN) | |||||
D08560 | Tamsulosin (INN); Flomax (TN); Tamsulon (TN) | |||||
D08569 | Terazosin (INN); Terazosabb (TN) | |||||
D08578 | Tetryzoline (INN); Tetrahydrozoline; Caltheon (TN) | |||||
D08614 | Tolazoline (INN); Tolazine [veterinary] (TN) | |||||
D08624 | Tramazoline (INN); Muconasal (TN) | |||||
D08662 | Urapidil hydrochloride; Ebrantil (TN) | |||||
D08684 | Xylometazoline (INN); Balminil (TN) | |||||
D08966 | Phenylephrine bitartrate (USP) | |||||
D09794 | Norepinephrine hydrochloride (JAN); (+/-)-Noradrenaline hydrochloride | |||||
D09842 | dl-Methylephedrine saccharinate (JAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...